路透社华盛顿3月6日 - 美国联邦贸易委员会周四提起诉讼，要求阻止医疗器械涂层制造商Surmodics公司SRDX.O被私募股权公司GTCR收购，该监管机构称这项交易是反竞争的。
美国联邦贸易委员会称，这笔交易将使合并后的公司控制50%以上的外包亲水涂层市场。
"监管机构在一份声明中说："医疗设备制造商经常使用这些涂层，并将其涂在导管和导丝等救生医疗设备上。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.